MedTrace Logo

An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana

NCT01836003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 422

Last updated 2024-01-05

No results posted yet for this study

Summary

Access to highly active antiretroviral therapy can improve maternal health outcomes for the 4000 HIV- infected women who give birth daily and nearly eliminate transmission of HIV to their infants. However, system inefficiencies, particularly CD4 testing to determine treatment eligibility, are barriers. The project aims to study the effectiveness of a programmatic intervention at improving antenatal access to treatment.

Conditions

  • HIV Infection
  • Pregnancy

Interventions

OTHER

Tokafatso programmatic intervention

Tokafatso programmatic intervention: * SMS-based platform for delivery of CD4 test results * Participatory educational session for clinic staff * Loan program for HIV and CD4 testing supplies * Facilitation of tracing of HAART-eligible pregnant women

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Scott Dryden-Peterson, MD · Harvard School of Public Health, Botswana Harvard AIDS Institute, Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Botswana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01836003 on ClinicalTrials.gov